Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
First Appeared on 6/14/2017
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|HPV4: HPV (GARDASIL) / MERCK & CO. INC.||J007883 / -||UN / UN|
Administered by: Other Purchased by: Other
Symptoms: Pain, Syncope
Life Threatening? No
Permanent Disability? Yes
ER or Doctor Visit? Yes
Hospitalized? Yes, days:
Write-up:Information has been received from Sanofi Pasteur MSD (SPM) (manufacturer control # IE-1577272925-E2015-12871) on 13-NOV-2015. This case was received from the health authority on 11-Nov-2015. Ref IE-HPRA-2015-025099. This case is not medically confirmed as the reporter is a consumer. A 13 year old female patient who was not taking any concomitant medication received injections of GARDASIL, (batch number J007883), route and site not reported, between 01-Nov-2013 and 26-Aug-2014. On 26-Aug-2014, post vaccination, the patient experienced chronic pain and fainting. Corrective treatment included pain killers and anti-inflammatories. At the time of reporting the patient''s symptoms were persisting. The reporter considered the events to be serious due to hospitalisation and disability.
Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166